Proposals to Improve the Public Health Workforce, Rural Health, and Over-the-Counter Medicines

Witnesses:

• Jacqueline Corrigan-Curay, JD, MD — Acting Director for Center for Drug, Evaluation and Research (CDER), U.S. Food and Drug Administration
• Candice Chen, MD, MPH — Acting Associate Administrator for Health, Workforce, U.S. Health Resources and Services Administration
• Tom Morris, MPA — Associate Administrator for Rural Health Policy, U.S., Health Resources and Services Administration

Items to be Considered:

• H.R. 4273 — Over-the-Counter Monograph Drug User Fee Amendments (Reps. Latta and DeGette)
• H.R. 3686 — SAFE Sunscreen Standards Act (Reps. Joyce of PA and Dingell)
• H.R. 2821 — FDA Modernization Act 3.0 (Reps. Carter of GA and Barragán)
• H.R. ____ — [Title VII Reauthorization]
• H.R. ____ — [Title VIII Reauthorization]
• H.R. 2493 — Improving Care in Rural America Reauthorization Act of 2025 (Reps. Carter of GA and Figures)
• H.R. 3419 — To amend the Public Health Service Act to reauthorize the telehealth network and telehealth resource centers grant programs. (Reps. Valadao and Gray)
• H.R. 3302 — Healthy Start Reauthorization Act of 2025 (Reps. Ocasio-Cortez and Malliotakis)
• H.R. 2846 — To amend title II of the Public Health Service Act to include as an additional right or privilege of commissioned officers of the Public Health Service (and their beneficiaries) certain leave provided under title 10, United States Code to commissioned officers of the Army (or their beneficiaries). (Reps. Houlahan and Bacon)
• H.R. ____ — [Newborn Screening Saves Lives Reauthorization Act of 2025]